Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Betterlife Pharma Inc (BETRF)

Betterlife Pharma Inc (BETRF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]

Fundamentals

See More
  • Market Capitalization, $K 10,618
  • Shares Outstanding, K 51,446
  • Annual Sales, $ 0 K
  • Annual Income, $ -27,200 K
  • 60-Month Beta 3.05
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade BETRF with:
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -1.00
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 09/27/21
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1716 +20.28%
on 08/23/21
0.2722 -24.17%
on 09/10/21
-0.0051 (-2.41%)
since 08/20/21
3-Month
0.1716 +20.28%
on 08/23/21
0.2908 -29.02%
on 07/27/21
-0.0336 (-14.00%)
since 06/18/21
52-Week
0.1716 +20.28%
on 08/23/21
1.7700 -88.34%
on 01/04/21
-0.5761 (-73.62%)
since 09/18/20

Most Recent Stories

More News
BetterLife to Present at the Emerging Growth Conference on September 15, 2021

BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR/ OTCQB: BETRF/ FRA: NPAU), an emerging biotechnology company primarily focused on developing compounds to treat neurological conditions,...

BETRF : 0.2064 (-11.00%)
BetterLife Enters Research Agreement with Medical College Wisconsin for TD-0148A Neurological Receptor Studies

BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotechnology company primarily focused on developing compounds to treat neurological conditions,...

BETRF : 0.2064 (-11.00%)
BetterLife Initiates Preclinical Study of AP-003 (rhIFNa2b) against Delta Variant of SARS-CoV-2

BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR/ OTCQB: BETRF/ FRA: NPAU), an emerging biotechnology company primarily focused on developing compounds to treat neurological conditions,...

BETRF : 0.2064 (-11.00%)
BetterLife Receives Approval to Conduct COVID-19 Randomized Placebo-Controlled Trial with Pontificia Universidad Catolica de Chile

BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR/ OTCQB: BETRF/ FRA: NPAU) today announced that its wholly owned subsidiary, Altum Pharmaceuticals Inc. ("Altum"), and Pontificia Universidad...

BETRF : 0.2064 (-11.00%)
BetterLife-Carleton University Research Team Secure Mitacs Accelerate Funding to Study the Therapeutic Effect of TD-010 in Chronic Anxiety

BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR/ OTCQB: BETRF/ FRA: NPAU), an emerging biotech company focused on developing compounds to treat neurological conditions, is pleased to...

BETRF : 0.2064 (-11.00%)
BetterLife to Present at the Emerging Growth Conference

BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR/ OTCQB: BETRF/ FRA:NPAU), an emerging biotechnology company primarily focused on developing compounds to treat neurological conditions,...

BETRF : 0.2064 (-11.00%)
Early Results of BetterLife Preclinical Study Showing AP-003 (rhIFNa2b) has Similar Potent Efficacy Against Different Variants of COVID-19

BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotechnology company primarily focused on developing compounds to treat neurological conditions,...

BETRF : 0.2064 (-11.00%)
BetterLife Provides H1 2021 Progress Update

BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotechnology company primarily focused on developing compounds to treat neurological conditions,...

BETRF : 0.2064 (-11.00%)
BetterLife Announces Exercise of Over-Allotment Option in Public Offering

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES

BETRF : 0.2064 (-11.00%)
BetterLife Secures Mitacs Funding in Collaboration with Carleton University Research Team for TD-0148A Preclinical Depression Studies

BetterLife Pharma Inc. ("BetterLife" or the "Company") (CSE: BETR / OTCQB: BETRF / FRA: NPAU), an emerging biotech company focused on the development and commercialization of cutting-edge treatments in...

BETRF : 0.2064 (-11.00%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 96% Sell with a Strengthening short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Key Turning Points

3rd Resistance Point 0.2733
2nd Resistance Point 0.2564
1st Resistance Point 0.2314
Last Price 0.2064
1st Support Level 0.1895
2nd Support Level 0.1726
3rd Support Level 0.1476

See More

52-Week High 1.7700
Fibonacci 61.8% 1.1594
Fibonacci 50% 0.9708
Fibonacci 38.2% 0.7822
Last Price 0.2064
52-Week Low 0.1716

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar